Paillas, Salome <br/><br/>
The Histone Deacetylase Inhibitor Romidepsin Spares Normal Tissues While Acting as an Effective Radiosensitizer in Bladder Tumors in Vivo.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  05 2020 
 - 212-221 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2020.01.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation--drug effects<br/>Cell Line, Tumor<br/>DNA Breaks, Double-Stranded--drug effects<br/>DNA Repair--drug effects<br/>Depsipeptides--adverse effects<br/>Histone Deacetylase Inhibitors--adverse effects<br/>Histones--metabolism<br/>Humans<br/>Organs at Risk--radiation effects<br/>Radiation-Sensitizing Agents--adverse effects<br/>Urinary Bladder Neoplasms--pathology<br/>Xenograft Model Antitumor Assays